Molecule Information
General Information of the Molecule (ID: Mol05297)
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
4 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Osteosarcoma [ICD-11: 2B51.0] | [1] | |||
| Resistant Disease | Osteosarcoma [ICD-11: 2B51.0] | |||
| Resistant Drug | Cisplatin | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 |
| MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 | |
| Experiment for Molecule Alteration |
RT-PCR | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | The most upregulated circRNA, miRNA, and mRNA were hsa_circ_0004674 (17-fold change), hsa-miR-337-3p (12-fold change), and C6orf106 (124-fold change), respectively. The most downregulated circRNA, miRNA, and mRNA were hsa_circ_0068458 (12-fold change), hsa-miR-203a-3p (10-fold change), and AKR1C2 (197-fold change), respectively. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Osteosarcoma [ICD-11: 2B51.0] | [1] | |||
| Resistant Disease | Osteosarcoma [ICD-11: 2B51.0] | |||
| Resistant Drug | Doxorubicin | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 |
| MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 | |
| Experiment for Molecule Alteration |
RT-PCR | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | The most upregulated circRNA, miRNA, and mRNA were hsa_circ_0004674 (17-fold change), hsa-miR-337-3p (12-fold change), and C6orf106 (124-fold change), respectively. The most downregulated circRNA, miRNA, and mRNA were hsa_circ_0068458 (12-fold change), hsa-miR-203a-3p (10-fold change), and AKR1C2 (197-fold change), respectively. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Osteosarcoma [ICD-11: 2B51.0] | [1] | |||
| Resistant Disease | Osteosarcoma [ICD-11: 2B51.0] | |||
| Resistant Drug | Ifosfamide | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 |
| MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 | |
| Experiment for Molecule Alteration |
RT-PCR | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | The most upregulated circRNA, miRNA, and mRNA were hsa_circ_0004674 (17-fold change), hsa-miR-337-3p (12-fold change), and C6orf106 (124-fold change), respectively. The most downregulated circRNA, miRNA, and mRNA were hsa_circ_0068458 (12-fold change), hsa-miR-203a-3p (10-fold change), and AKR1C2 (197-fold change), respectively. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Osteosarcoma [ICD-11: 2B51.0] | [1] | |||
| Resistant Disease | Osteosarcoma [ICD-11: 2B51.0] | |||
| Resistant Drug | Methotrexate | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 |
| MG63 cells | Bone marrow | Homo sapiens (Human) | CVCL_0426 | |
| Experiment for Molecule Alteration |
RT-PCR | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | The most upregulated circRNA, miRNA, and mRNA were hsa_circ_0004674 (17-fold change), hsa-miR-337-3p (12-fold change), and C6orf106 (124-fold change), respectively. The most downregulated circRNA, miRNA, and mRNA were hsa_circ_0068458 (12-fold change), hsa-miR-203a-3p (10-fold change), and AKR1C2 (197-fold change), respectively. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
